FMR LLC - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
FMR LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$384,000
-78.6%
952,369
-80.2%
0.00%
Q3 2016$1,797,000
-53.8%
4,800,000
-58.1%
0.00%
-100.0%
Q2 2016$3,891,000
-69.2%
11,445,259
-51.9%
0.00%
-50.0%
Q1 2016$12,638,000
-63.2%
23,782,248
-14.8%
0.00%
-60.0%
Q4 2015$34,341,000
+141.1%
27,919,722
+186.2%
0.01%
+150.0%
Q3 2015$14,241,000
-18.1%
9,753,954
+9.3%
0.00%0.0%
Q2 2015$17,395,000
+15.9%
8,920,707
+7.6%
0.00%0.0%
Q1 2015$15,008,000
+87.5%
8,291,688
+144.4%
0.00%
+100.0%
Q4 2014$8,005,000
-2.5%
3,392,1300.0%0.00%0.0%
Q3 2014$8,209,000
-13.9%
3,392,1300.0%0.00%0.0%
Q2 2014$9,532,0003,392,1300.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2017
NameSharesValueWeighting ↓
PYRRHO CAPITAL MANAGEMENT, LP 608,194$1,186,0000.58%
Lombard Odier Asset Management (USA) Corp 2,768,341$5,398,0000.38%
Rotella Capital Management, Inc. 43,666$85,0000.07%
TWO SIGMA SECURITIES, LLC 19,994$39,0000.06%
OXFORD ASSET MANAGEMENT LLP 1,214,227$2,368,0000.06%
Candriam S.C.A. 1,445,000$2,818,0000.06%
WASHINGTON TRUST Co 410,616$801,0000.05%
DRW Securities, LLC 250,000$488,0000.05%
GLOBEFLEX CAPITAL L P 120,000$234,0000.04%
First Heartland Consultants, Inc. 74,624$146,0000.04%
View complete list of CTI BIOPHARMA CORP shareholders